CoChat

Multiple pals gene modules control a balance between immunity and development in Caenorhabditis elegans

Open access

Preprint — published as 10.1371/journal.ppat.1011120

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The immune system continually battles against pathogen-induced pressures, which often leads to the evolutionary expansion of immune gene families in a species-specific manner. For example, the pals gene family expanded to 39 members in the Caenorhabditis elegans genome, in comparison to a single mammalian pals ortholog. Our previous studies have revealed that two members of this family, pals-22 and pals-25 , act as antagonistic paralogs to control the Intracellular Pathogen Response (IPR). The IPR is a protective transcriptional response, which is activated upon infection by two molecularly distinct natural intracellular pathogens of C. elegans – the Orsay virus and the fungus Nematocida parisii from the microsporidia phylum. In this study, we identify a previously uncharacterized member of the pals family, pals-17 , as a newly described negative regulator of the IPR. pals-17 mutants show constitutive upregulation of IPR gene expression, increased immunity against intracellular pathogens, as well as impaired development and reproduction. We also find that two other previously uncharacterized pals genes, pals-20 and pals-16 , are positive regulators of the IPR, acting downstream of pals-17 . These positive regulators reverse the effects caused by the loss of pals-17 on IPR gene expression, immunity and development. We show that the negative IPR regulator protein PALS-17 and the positive IPR regulator protein PALS-20 colocalize inside intestinal epithelial cells, which are the sites of infection for IPR-inducing pathogens. In summary, our study demonstrates that several pals genes from the expanded pals gene family act as ON/OFF switch modules to regulate a balance between organismal development and immunity against natural intracellular pathogens in C. elegans . AUTHOR SUMMARY: Immune responses to pathogens induce extensive rewiring of host physiology. In the short term, these changes are generally beneficial as they can promote resistance against infection. However, prolonged activation of immune responses can have serious negative consequences on host health, including impaired organismal development and fitness. Therefore, the balance between activating the immune system and promoting development must be precisely regulated. In this study, we used genetics to identify a gene in the roundworm Caenorhabditis elegans called pals-17 that acts as a repressor of the Intracellular Pathogen Response (IPR), a defense response against viral and microsporidian infections. We also found that pals-17 is required for the normal development of these animals. Furthermore, we identified two other pals genes, pals-20 and pals-16 , as suppressors of pals-17 mutant phenotypes. Finally, we found that PALS-17 and PALS-20 proteins colocalize inside intestinal cells, where viruses and microsporidia invade and replicate in the host. Taken together, our study demonstrates a balance between organismal development and immunity that is regulated by several genetic ON/OFF switch ‘modules’ in C. elegans .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2023.01.15.524171

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 pals-17 is a negative regulator of pals-5p::GFP expression. (A-D) pals-17(jy74) mutants show increased pals-5p::GFP expression. Representative images of synchronized populations of the control pals-22(-) pals-25(-) strain and pals-22(-) pals-25(-) pals-17(jy74) mutants grown for 24 h (A) or 44 h (B) at 20°C from L1 stage. Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bars, 50 μm (A) and 200 μm (B). Levels of pals-5p::GFP expression standardized to time-of-flight (TOF) are indicated by box-and-whisker plots for the control strain and pals-17(jy74) mutants grown for 24 h (C) or 44 h (D) at 20°C from L1 stage. (E) pals-17 gene structure. Exons are indicated with red boxes, 5’ and 3’ UTRs are shown with pink boxes. jy74 mutation, indicated with vertical arrow, alters the predicted splice site for the fourth exon. The horizontal arrow indicates the direction of transcription. (F) A rescuing fosmid containing wild-type pals-17, injected together with the myo-3p::mCherry body-wall muscle marker, reduces pals-5p::GFP expression in pals-17(jy74) mutant animals (right), compared to their pals-17(jy74) mutant siblings that do not contain the fosmid (left). Red, green and DIC channels were merged in the composite images. myo-2p::mCherry and myo-3p::mCherry co-injection markers are shown in red. Scale bar, 100 μm. (G-J) pals-17 RNAi increases pals-5p::GFP expression in pals-22(-) pals-25(-) mutants and wild-type animals. Representative images of synchronized L4 stage populations of the pals-22(-) pals-25(-) (G) and wild-type animals (I) grown on the control RNAi vector and pals-17 RNAi plates. Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bars, 50 μm. (H, J) Box-and-whisker plots of pals-5p::GFP expression levels standardized to TOF following control RNAi and pals-17 RNAi treatments of pals-22(-) pals-25(-) mutants (H) and wild-type animals (J). (C, D, H, J) Lines in box-and-whisker plots represent the medians, box bounds indicate 25th and 75th percentiles, and whiskers extend from the box bounds to the minimum and maximum values. Green dots represent individual values for each animal; 600 (C), 800 (D), 1200 (H) and 750 animals (J) were analyzed per strain per each of the three replicates. A Kolmogorov-Smirnov test was used to calculate p-values; **** p < 0.0001.
Fig 1 pals-17 is a negative regulator of pals-5p::GFP expression. (A-D) pals-17(jy74) mutants show increased pals-5p::GFP expression. Representative images of synchronized populations of the control pals-22(-) pals-25(-) strain and pals-22(-) pals-25(-) pals-17(jy74) mutants grown for 24 h (A) or 44 h (B) at 20°C from L1 stage. Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bars, 50 μm (A) and 200 μm (B). Levels of pals-5p::GFP expression standardized to time-of-flight (TOF) are indicated by box-and-whisker plots for the control strain and pals-17(jy74) mutants grown for 24 h (C) or 44 h (D) at 20°C from L1 stage. (E) pals-17 gene structure. Exons are indicated with red boxes, 5’ and 3’ UTRs are shown with pink boxes. jy74 mutation, indicated with vertical arrow, alters the predicted splice site for the fourth exon. The horizontal arrow indicates the direction of transcription. (F) A rescuing fosmid containing wild-type pals-17, injected together with the myo-3p::mCherry body-wall muscle marker, reduces pals-5p::GFP expression in pals-17(jy74) mutant animals (right), compared to their pals-17(jy74) mutant siblings that do not contain the fosmid (left). Red, green and DIC channels were merged in the composite images. myo-2p::mCherry and myo-3p::mCherry co-injection markers are shown in red. Scale bar, 100 μm. (G-J) pals-17 RNAi increases pals-5p::GFP expression in pals-22(-) pals-25(-) mutants and wild-type animals. Representative images of synchronized L4 stage populations of the pals-22(-) pals-25(-) (G) and wild-type animals (I) grown on the control RNAi vector and pals-17 RNAi plates. Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bars, 50 μm. (H, J) Box-and-whisker plots of pals-5p::GFP expression levels standardized to TOF following control RNAi and pals-17 RNAi treatments of pals-22(-) pals-25(-) mutants (H) and wild-type animals (J). (C, D, H, J) Lines in box-and-whisker plots represent the medians, box bounds indicate 25th and 75th percentiles, and whiskers extend from the box bounds to the minimum and maximum values. Green dots represent individual values for each animal; 600 (C), 800 (D), 1200 (H) and 750 animals (J) were analyzed per strain per each of the three replicates. A Kolmogorov-Smirnov test was used to calculate p-values; **** p < 0.0001.CC BY · PubMed Central
Fig 2 pals-17 mutant phenotypes are partially dependent on pals-20. (A) Representative images of pals-5p::GFP expression in pals-22(-) pals-25(-) pals-17(jy74) mixed stage animals on control and pals-20 RNAi plates. Green, red and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bar, 200 μm. (B) pals-17 and pals-20 gene structures. pals-17 exons are indicated with red boxes, 5’ and 3’ UTRs are shown with pink boxes. pals-20 exons are indicated with yellow boxes. Vertical arrows indicate the positions of the point mutations that create premature stop codons in pals-17 and pals-20. Horizontal arrows indicate the directions of transcription. (C) Fractions of animals reaching the L4 or adult stage at 44, 64 and 72 hours after eggs were laid. Results are averages of three independent experimental replicates, with 100 animals in each replicate at each time point. Error bars are standard deviations (SD). Ordinary one-way ANOVA test was used to calculate p-values; **** p < 0.0001; ** p < 0.01; * p < 0.05; ns indicates no significant difference. (D-F) pals-20 mutation suppresses increased expression of IPR genes in the pals-17 mutant background at early life stages. qRT-PCR of IPR gene expression shown as the mean fold changes relative to the wild-type control at L1 (D), L2 (E) and L4 stage (F). Error bars are SD. A one-tailed t-test was used to calculate p-values; black asterisks represent a significant difference between the labeled sample and the wild-type control; red asterisks represent a significant difference between pals-17(*) and pals-17(*) pals-20(*) samples; *** p < 0.001; ** p < 0.01; * p < 0.05; p-values higher than 0.05 are not labeled.
Fig 2 pals-17 mutant phenotypes are partially dependent on pals-20. (A) Representative images of pals-5p::GFP expression in pals-22(-) pals-25(-) pals-17(jy74) mixed stage animals on control and pals-20 RNAi plates. Green, red and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bar, 200 μm. (B) pals-17 and pals-20 gene structures. pals-17 exons are indicated with red boxes, 5’ and 3’ UTRs are shown with pink boxes. pals-20 exons are indicated with yellow boxes. Vertical arrows indicate the positions of the point mutations that create premature stop codons in pals-17 and pals-20. Horizontal arrows indicate the directions of transcription. (C) Fractions of animals reaching the L4 or adult stage at 44, 64 and 72 hours after eggs were laid. Results are averages of three independent experimental replicates, with 100 animals in each replicate at each time point. Error bars are standard deviations (SD). Ordinary one-way ANOVA test was used to calculate p-values; **** p < 0.0001; ** p < 0.01; * p < 0.05; ns indicates no significant difference. (D-F) pals-20 mutation suppresses increased expression of IPR genes in the pals-17 mutant background at early life stages. qRT-PCR of IPR gene expression shown as the mean fold changes relative to the wild-type control at L1 (D), L2 (E) and L4 stage (F). Error bars are SD. A one-tailed t-test was used to calculate p-values; black asterisks represent a significant difference between the labeled sample and the wild-type control; red asterisks represent a significant difference between pals-17(*) and pals-17(*) pals-20(*) samples; *** p < 0.001; ** p < 0.01; * p < 0.05; p-values higher than 0.05 are not labeled.CC BY · PubMed Central
Fig 3 pals-17 mutant phenotypes are fully pals-16-dependent. (A, B) pals-16 RNAi decreases pals-5p::GFP expression in pals-17 pals-20 mutants. (A) Representative images of synchronized pals-17(*) pals-20(*) mutants grown on control or pals-16 RNAi plates for 72 h at 20°C. Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bar, 200 μm. (B) Box-and-whisker plot of pals-5p::GFP expression levels of (A) adjusted to background fluorescence for each sample. Line represents median, box bounds indicate 25th and 75th percentiles, and whiskers indicate minimum and maximum values. Green dots represent individual values for each animal; 50 animals were analyzed per strain per each of the three replicates. A Kolmogorov-Smirnov test was used to calculate p-values; **** p < 0.0001. AU = arbitrary units. (C) pals-16, pals-17 and pals-20 gene structures. pals-16 exons indicated with dark green boxes, 5’ and 3’ UTRs with light green boxes. pals-17 exons indicated with red boxes, 5’ and 3’ UTRs as pink boxes. pals-20 exons indicated with yellow boxes. Bracket under green boxes demarks approximate area deleted in jy171, jy174 and jy182 pals-16 alleles (pals-16(Δ)). Vertical arrows indicate positions of point mutations that create premature stop codons in pals-17 and pals-20. Horizontal arrows indicate directions of transcription. (D) Fractions of animals reaching L4 or adult stage at 44, 64 and 72 hours after eggs were laid. Results shown are the average of three independent experimental replicates, with 100 animals assayed in each replicate at each time point. Error bars are SD. An ordinary one-way ANOVA test was used to calculate p-values; **** p < 0.0001. (E, F) pals-16 mutation suppresses increased expression of several IPR genes in the pals-17(*) and pals-17(*) pals-20(*) backgrounds. qRT-PCR measurements of gene expression are shown as the fold change relative to the wild-type control at L4 (E) and L1 stage (F). Mean values shown, error bars are SD. A one-tailed t-test was used to calculate p-values; black asterisks represent a significant difference between the labeled sample and wild-type control; red asterisks represent significant differences between pals-17(*) pals-20(*) and either pals-16(Δ) pals-17(*) or pals-16(Δ) pals-17(*) pals-20(*) (E), and significant differences between pals-17(*) and either pals-16(Δ) pals-17(*) or pals-16(Δ) pals-17(*) pals-20(*) (F); ** p < 0.01; * p < 0.05; p-values higher than 0.05 are not labeled.
Fig 3 pals-17 mutant phenotypes are fully pals-16-dependent. (A, B) pals-16 RNAi decreases pals-5p::GFP expression in pals-17 pals-20 mutants. (A) Representative images of synchronized pals-17(*) pals-20(*) mutants grown on control or pals-16 RNAi plates for 72 h at 20°C. Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. Scale bar, 200 μm. (B) Box-and-whisker plot of pals-5p::GFP expression levels of (A) adjusted to background fluorescence for each sample. Line represents median, box bounds indicate 25th and 75th percentiles, and whiskers indicate minimum and maximum values. Green dots represent individual values for each animal; 50 animals were analyzed per strain per each of the three replicates. A Kolmogorov-Smirnov test was used to calculate p-values; **** p < 0.0001. AU = arbitrary units. (C) pals-16, pals-17 and pals-20 gene structures. pals-16 exons indicated with dark green boxes, 5’ and 3’ UTRs with light green boxes. pals-17 exons indicated with red boxes, 5’ and 3’ UTRs as pink boxes. pals-20 exons indicated with yellow boxes. Bracket under green boxes demarks approximate area deleted in jy171, jy174 and jy182 pals-16 alleles (pals-16(Δ)). Vertical arrows indicate positions of point mutations that create premature stop codons in pals-17 and pals-20. Horizontal arrows indicate directions of transcription. (D) Fractions of animals reaching L4 or adult stage at 44, 64 and 72 hours after eggs were laid. Results shown are the average of three independent experimental replicates, with 100 animals assayed in each replicate at each time point. Error bars are SD. An ordinary one-way ANOVA test was used to calculate p-values; **** p < 0.0001. (E, F) pals-16 mutation suppresses increased expression of several IPR genes in the pals-17(*) and pals-17(*) pals-20(*) backgrounds. qRT-PCR measurements of gene expression are shown as the fold change relative to the wild-type control at L4 (E) and L1 stage (F). Mean values shown, error bars are SD. A one-tailed t-test was used to calculate p-values; black asterisks represent a significant difference between the labeled sample and wild-type control; red asterisks represent significant differences between pals-17(*) pals-20(*) and either pals-16(Δ) pals-17(*) or pals-16(Δ) pals-17(*) pals-20(*) (E), and significant differences between pals-17(*) and either pals-16(Δ) pals-17(*) or pals-16(Δ) pals-17(*) pals-20(*) (F); ** p < 0.01; * p < 0.05; p-values higher than 0.05 are not labeled.CC BY · PubMed Central
Fig 4 RNA-seq analyses demonstrate that pals-17, pals-20 and pals-16 regulate the expression of many genes at the L4 stage. (A-C) Venn diagram comparisons of genes upregulated in different genetic backgrounds. All RNA-seq analyses were done in this study, except pals-22(-)-upregulated genes and IPR genes, which were determined in previous studies [9,10]. (A) pals-17 is a negative regulator of IPR genes. Upregulated genes in pals-17(*) and pals-22(-) mutants as compared to wild-type (WT) animals, and to IPR genes. Upregulated genes in pals-17(*) mutants have significant overlap with those upregulated in pals-22(-) mutants (representation factor (rf) = 3.4; p < 5.788e-87) and with IPR genes (rf = 5.1; p < 2.155e-43). (B) IPR genes are still upregulated in pals-17 pals-20 double mutant L4 animals. Upregulated genes in pals-17(*) pals-20(*) mutants as compared to WT have significant overlap with those upregulated in pals-22(-) mutants as compared to WT (rf = 38.1; p < 8.209e-314) and to IPR genes (rf = 76.5; p < 5.950e-121). (C) Upregulated genes in pals-17(*) mutants have significant overlap with those upregulated in pals-17(*) pals-20(*) mutants (rf = 5.3; p < 2.983e-111), both as compared to WT. Mutations in pals-16 suppress genes upregulated in pals-17 mutant backgrounds. Upregulated genes in pals-17(*) mutants when compared to WT show significant overlap with genes upregulated in pals-17(*) pals-20(*) mutants that are dependent on pals-16 (rf = 5.1; p < 8.191e-106). Upregulated genes in pals-17(*) pals-20(*) mutants when compared to WT and pals-16(Δ) pals-17(*) pals-20(*) show significant overlap (rf = 84.3; p < 0.000e+00). (A-C) rf is the ratio of actual overlap to expected overlap where rf > 1 indicates overrepresentation and rf < 1 indicates underrepresentation. The numbers outside the circles represent the total number of genes in each dataset. (D, E) Enriched gene categories for pals-17(*)-dependent (D) and pals-17(*) pals-20(*)-dependent genes (E). Each category represents a biological process or a structure. The count of genes found in each category is indicated on the x-axis. Statistical significance for each category is indicated by the bar color; p-values are indicated in the legend on the right. p-values were determined using Bonferroni correction from the minimum hypergeometric scores calculated by the WormCat software. Source data (including p-values) are provided in S1 Table. Y = tyrosine; ZF = zinc finger. (F) Correlation of differentially expressed genes in pals-17(*) and pals-17(*) pals-20(*) mutants (in comparison to WT) with the genes that are differentially expressed during infection and exposure to other stressors. The correlation of gene sets was quantified as Normalized Enrichment Score (NES) as defined by GSEAPreranked module analysis. Yellow indicates a significant correlation of upregulated genes in pals-17(*) and/or pals-17(*) pals-20(*) mutants with the gene sets tested; grey indicates no significant correlation (p > 0.05 or False Discovery Rate > 0.25); blue indicates a significant correlation of downregulated genes in pals-17(*) and/or pals-17(*) pals-20(*) mutants with the gene sets tested. GSEA analysis of 93 gene sets tested and lists of genes are provided in S1 and S5 Tables.
Fig 4 RNA-seq analyses demonstrate that pals-17, pals-20 and pals-16 regulate the expression of many genes at the L4 stage. (A-C) Venn diagram comparisons of genes upregulated in different genetic backgrounds. All RNA-seq analyses were done in this study, except pals-22(-)-upregulated genes and IPR genes, which were determined in previous studies [9,10]. (A) pals-17 is a negative regulator of IPR genes. Upregulated genes in pals-17(*) and pals-22(-) mutants as compared to wild-type (WT) animals, and to IPR genes. Upregulated genes in pals-17(*) mutants have significant overlap with those upregulated in pals-22(-) mutants (representation factor (rf) = 3.4; p < 5.788e-87) and with IPR genes (rf = 5.1; p < 2.155e-43). (B) IPR genes are still upregulated in pals-17 pals-20 double mutant L4 animals. Upregulated genes in pals-17(*) pals-20(*) mutants as compared to WT have significant overlap with those upregulated in pals-22(-) mutants as compared to WT (rf = 38.1; p < 8.209e-314) and to IPR genes (rf = 76.5; p < 5.950e-121). (C) Upregulated genes in pals-17(*) mutants have significant overlap with those upregulated in pals-17(*) pals-20(*) mutants (rf = 5.3; p < 2.983e-111), both as compared to WT. Mutations in pals-16 suppress genes upregulated in pals-17 mutant backgrounds. Upregulated genes in pals-17(*) mutants when compared to WT show significant overlap with genes upregulated in pals-17(*) pals-20(*) mutants that are dependent on pals-16 (rf = 5.1; p < 8.191e-106). Upregulated genes in pals-17(*) pals-20(*) mutants when compared to WT and pals-16(Δ) pals-17(*) pals-20(*) show significant overlap (rf = 84.3; p < 0.000e+00). (A-C) rf is the ratio of actual overlap to expected overlap where rf > 1 indicates overrepresentation and rf < 1 indicates underrepresentation. The numbers outside the circles represent the total number of genes in each dataset. (D, E) Enriched gene categories for pals-17(*)-dependent (D) and pals-17(*) pals-20(*)-dependent genes (E). Each category represents a biological process or a structure. The count of genes found in each category is indicated on the x-axis. Statistical significance for each category is indicated by the bar color; p-values are indicated in the legend on the right. p-values were determined using Bonferroni correction from the minimum hypergeometric scores calculated by the WormCat software. Source data (including p-values) are provided in S1 Table. Y = tyrosine; ZF = zinc finger. (F) Correlation of differentially expressed genes in pals-17(*) and pals-17(*) pals-20(*) mutants (in comparison to WT) with the genes that are differentially expressed during infection and exposure to other stressors. The correlation of gene sets was quantified as Normalized Enrichment Score (NES) as defined by GSEAPreranked module analysis. Yellow indicates a significant correlation of upregulated genes in pals-17(*) and/or pals-17(*) pals-20(*) mutants with the gene sets tested; grey indicates no significant correlation (p > 0.05 or False Discovery Rate > 0.25); blue indicates a significant correlation of downregulated genes in pals-17(*) and/or pals-17(*) pals-20(*) mutants with the gene sets tested. GSEA analysis of 93 gene sets tested and lists of genes are provided in S1 and S5 Tables.CC BY · PubMed Central
Fig 5 PALS-17 and PALS-20 colocalize in the intestine. (A, B) Expression of pals-17p::GFP (A) and pals-20p::wrmScarlet transcriptional reporters (B) in the intestine and head. In upper images, for a few worms, intestine is indicated with white dotted line and head is indicated with asterisk; in lower images expression in the head region is indicated with white arrows. For comparison, the wild-type control is provided for each transgenic strain. Scale bars, 200 μm (upper images) and 50 μm (lower images). (C) Expression of PALS-17::GFP and PALS-20::wrmScarlet translational reporters and their colocalization. Representative images showing separate green and red channels, as well as their overlap and overlap with DIC. Arrowheads indicate colocalization of fluorophores at the border with the intestinal lumen; arrows indicate areas of colocalization in other regions of intestinal cells. Scale bar, 20 μm.
Fig 5 PALS-17 and PALS-20 colocalize in the intestine. (A, B) Expression of pals-17p::GFP (A) and pals-20p::wrmScarlet transcriptional reporters (B) in the intestine and head. In upper images, for a few worms, intestine is indicated with white dotted line and head is indicated with asterisk; in lower images expression in the head region is indicated with white arrows. For comparison, the wild-type control is provided for each transgenic strain. Scale bars, 200 μm (upper images) and 50 μm (lower images). (C) Expression of PALS-17::GFP and PALS-20::wrmScarlet translational reporters and their colocalization. Representative images showing separate green and red channels, as well as their overlap and overlap with DIC. Arrowheads indicate colocalization of fluorophores at the border with the intestinal lumen; arrows indicate areas of colocalization in other regions of intestinal cells. Scale bar, 20 μm.CC BY · PubMed Central
Fig 6 pals-17, pals-20, and pals-16 play a role in immunity against intracellular pathogens. (A, B) Fractions of animals infected with the Orsay virus in indicated genetic backgrounds. Animals were inoculated with the pathogen from the L1 (A) or L4 stage (B). Animals were scored based on the presence or absence of the Orsay virus-specific FISH probe fluorescence (six experimental replicates, at least 300 animals per replicate). Red dots represent the infection level for each replicate; the wild type was set at one for each replicate. Error bars are SD. An ordinary one-way ANOVA test was used to calculate p-values; **** p < 0.0001. (C, D) Quantification of N. parisii-specific FISH fluorescence signal standardized to time-of-flight (TOF). Animals were inoculated with pathogen from the L1 (C) or L4 stage (D), and analyzed at 30 hpi. 600 (C) and 750 animals (D) were analyzed per strain in three experimental replicates. Red dots in the box-and-whisker plots represent individual values for each analyzed animal. Box lines represent median values, box bounds indicate 25th and 75th percentiles, and whiskers extend to the minimum and maximum values. A Kruskal-Wallis test was used to calculate p-values; **** p < 0.0001. (E, F) pals-5p::7xGFP reporter expression is induced in animals overexpressing pals-20::wrmScarlet construct. (E) Representative images of synchronized animals 72 hours-after L1 overexpressing pals-20::wrmScarlet myo-2p::mCherry array and their siblings that do not overexpress pals-20 (control). Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. PALS-20::wrmScarlet is not visible with the exposure setting that was used for imaging. Scale bar, 200 μm. (F) Quantification of pals-5p::7xGFP expression in pals-20::wrmScarlet overexpressing strain and their siblings that do not overexpress pals-20 (control). Green dots in the box-and-whisker plots represent individual values for each analyzed animal; 50 animals were analyzed per strain for each of the three experimental replicates. Box lines represents median value, box bounds indicate 25th and 75th percentiles, and whiskers extend to the minimum and maximum values. A Kolmogorov-Smirnov test was used to calculate p-values; **** p < 0.0001. AU = arbitrary units. (G) Fractions of animals overexpressing pals-20::wrmScarlet construct and their non-transgenic siblings that are infected with Orsay virus. Animals were scored based on the presence or absence of the Orsay virus-specific FISH probe fluorescence (six experimental replicates, at least 300 animals per replicate). Green dots represent the infection level for each replicate; the wild type was set at one for each replicate. Error bars are SD. A one sample Wilcoxon test was used to calculate the p-value; * p < 0.05.
Fig 6 pals-17, pals-20, and pals-16 play a role in immunity against intracellular pathogens. (A, B) Fractions of animals infected with the Orsay virus in indicated genetic backgrounds. Animals were inoculated with the pathogen from the L1 (A) or L4 stage (B). Animals were scored based on the presence or absence of the Orsay virus-specific FISH probe fluorescence (six experimental replicates, at least 300 animals per replicate). Red dots represent the infection level for each replicate; the wild type was set at one for each replicate. Error bars are SD. An ordinary one-way ANOVA test was used to calculate p-values; **** p < 0.0001. (C, D) Quantification of N. parisii-specific FISH fluorescence signal standardized to time-of-flight (TOF). Animals were inoculated with pathogen from the L1 (C) or L4 stage (D), and analyzed at 30 hpi. 600 (C) and 750 animals (D) were analyzed per strain in three experimental replicates. Red dots in the box-and-whisker plots represent individual values for each analyzed animal. Box lines represent median values, box bounds indicate 25th and 75th percentiles, and whiskers extend to the minimum and maximum values. A Kruskal-Wallis test was used to calculate p-values; **** p < 0.0001. (E, F) pals-5p::7xGFP reporter expression is induced in animals overexpressing pals-20::wrmScarlet construct. (E) Representative images of synchronized animals 72 hours-after L1 overexpressing pals-20::wrmScarlet myo-2p::mCherry array and their siblings that do not overexpress pals-20 (control). Red, green and DIC channels were merged. myo-2p::mCherry co-injection marker is shown in red. PALS-20::wrmScarlet is not visible with the exposure setting that was used for imaging. Scale bar, 200 μm. (F) Quantification of pals-5p::7xGFP expression in pals-20::wrmScarlet overexpressing strain and their siblings that do not overexpress pals-20 (control). Green dots in the box-and-whisker plots represent individual values for each analyzed animal; 50 animals were analyzed per strain for each of the three experimental replicates. Box lines represents median value, box bounds indicate 25th and 75th percentiles, and whiskers extend to the minimum and maximum values. A Kolmogorov-Smirnov test was used to calculate p-values; **** p < 0.0001. AU = arbitrary units. (G) Fractions of animals overexpressing pals-20::wrmScarlet construct and their non-transgenic siblings that are infected with Orsay virus. Animals were scored based on the presence or absence of the Orsay virus-specific FISH probe fluorescence (six experimental replicates, at least 300 animals per replicate). Green dots represent the infection level for each replicate; the wild type was set at one for each replicate. Error bars are SD. A one sample Wilcoxon test was used to calculate the p-value; * p < 0.05.CC BY · PubMed Central
Fig 7 Models for regulation of development and immunity by PALS-17, PALS-20, and PALS-16 in C. elegans. (A) PALS-17 is a negative IPR regulator acting upstream of the positive IPR regulators PALS-20 and PALS-16, similar to how PALS-22 is a negative IPR regulator acting upstream of the positive IPR regulator PALS-25. (B, C) When PALS-17 is absent, PALS-20 and PALS-16 inhibit development and activate the IPR, similar to how PALS-25 inhibits development and activates the IPR when PALS-22 is absent. When PALS-17 or PALS-22 are absent, the transcription factor ZIP-1 appears in nuclei, and activates IPR gene expression, and promotes pathogen resistance. Created with BioRender.com.
Fig 7 Models for regulation of development and immunity by PALS-17, PALS-20, and PALS-16 in C. elegans. (A) PALS-17 is a negative IPR regulator acting upstream of the positive IPR regulators PALS-20 and PALS-16, similar to how PALS-22 is a negative IPR regulator acting upstream of the positive IPR regulator PALS-25. (B, C) When PALS-17 is absent, PALS-20 and PALS-16 inhibit development and activate the IPR, similar to how PALS-25 inhibits development and activates the IPR when PALS-22 is absent. When PALS-17 or PALS-22 are absent, the transcription factor ZIP-1 appears in nuclei, and activates IPR gene expression, and promotes pathogen resistance. Created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 81

  1. Chan C . Progress in Salicylic Acid-Dependent Signaling for Growth-Defense Trade-Off. Cells. 2022;11(19). · DOI
  2. 2019, Recalculating growth and defense strategies under competition: key roles of photoreceptors and jasmonates, J Exp Bot, 70, 3425, 10.1093/jxb/erz237 · DOI
  3. 10.1105/tpc.16.00931 · DOI · Paper page
  4. 10.1371/journal.ppat.1007528 · DOI
  5. 2022, A pals-25 gain-of-function allele triggers systemic resistance against natural pathogens of C. elegans, PLoS Genet, 18, e1010314, 10.1371/journal.pgen.1010314 · DOI
  6. 10.1016/j.cub.2017.10.009 · DOI
  7. 10.1371/journal.ppat.1004200 · DOI · Paper page
  8. 10.1111/cmi.12152 · DOI
  9. 10.1016/bs.ctdb.2020.1 · doi:10.1016/bs.ctdb.2020.1
  10. 2022, Insights from C. elegans into Microsporidia Biology and Host-Pathogen Relationships, Exp Suppl, 114, 115
  11. 10.1534/genetics.117.300134 · DOI
  12. 2021, Conservation lost: host-pathogen battles drive diversification and expansion of gene families, FEBS J, 288, 5289, 10.1111/febs.15627 · DOI
  13. 2022, C. elegans: out on an evolutionary limb, Immunogenetics, 74, 63, 10.1007/s00251-021-01231-8 · doi:10.1007/s00251-021-01231-8
  14. 2022, The transcription factor ZIP-1 promotes resistance to intracellular infection in Caenorhabditis elegans, Nat Commun, 13, 17, 10.1038/s41467-021-27621-w · DOI
  15. 10.1534/genetics.119.302919 · DOI · Paper page
  16. 10.1073/pnas.0506580102 · DOI · Paper page
  17. 10.1038/ng1180 · DOI · Paper page
  18. Sowa JN , Jiang H , Somasundaram L , Tecle E , Xu G , Wang D , et al. The Caenorhabditis elegans RIG-I Homolog DRH-1 Mediates the Intracellular Pathogen Response upon Viral Infection. J Virol. 2020;94(2). · DOI
  19. 10.1371/journal.pbio.1001358 · DOI · Paper page
  20. 10.7554/eLife.01298 · DOI · Paper page
  21. 10.1371/journal.ppat.1004449 · DOI
  22. 10.1371/journal.ppat.1006376 · DOI
  23. 2014, Arabidopsis dual resistance proteins, both RPS4 and RRS1, are required for resistance to bacterial wilt in transgenic Brassica crops, Plant Signal Behav, 9, e29130, 10.4161/psb.29130 · doi:10.4161/psb.29130
  24. 10.1038/ncomms7338 · DOI · Paper page
  25. Mukhi N , Brown H , Gorenkin D , Ding P , Bentham AR , Stevenson CEM , et al. Perception of structurally distinct effectors by the integrated WRKY domain of a plant immune receptor. Proc Natl Acad Sci U S A. 2021;118(50). · DOI
  26. 2016, Coordinated inhibition of C/EBP by Tribbles in multiple tissues is essential for Caenorhabditis elegans development, BMC Biology, 14, 104, 10.1186/s12915-016-0320-z · DOI
  27. Cheesman HK , Feinbaum RL , Thekkiniath J , Dowen RH , Conery AL , Pukkila-Worley R . Aberrant Activation of p38 MAP Kinase-Dependent Innate Immune Responses Is Toxic to Caenorhabditis elegans. G3 (Bethesda). 2016;6(3):541–9. · DOI
  28. 2022, Gut commensal E. coli outer membrane proteins activate the host food digestive system through neural-immune communication, Cell Host Microbe, 30, 1401, 10.1016/j.chom.2022.08.004 · DOI
  29. 10.1186/s12915-016-0334-6 · DOI
  30. 2022, Forward genetic screening identifies novel roles for N-terminal acetyltransferase C and histone deacetylase in C. elegans development, Sci Rep, 12, 16438, 10.1038/s41598-022-20361-x · DOI
  31. 10.1016/j.celrep.2021.109529 · DOI
  32. 2022, TNF overexpression and dexamethasone treatment impair chondrogenesis and bone growth in an additive manner, Sci Rep, 12, 18189, 10.1038/s41598-022-22734-8 · doi:10.1038/s41598-022-22734-8
  33. 10.1016/j.immuni.2018.07.017 · DOI · Paper page
  34. 10.1523/JNEUROSCI.2178-07.2007 · DOI · Paper page
  35. 10.1126/science.aad0314 · DOI · Paper page
  36. 10.1152/ajplung.00154.2013 · DOI
  37. 10.1111/aji.12216 · DOI
  38. 10.1016/j.mcn.2004.08.004 · DOI
  39. 10.1002/ajmg.a.36887 · DOI · Paper page
  40. 10.1093/jn/125.4.908 · DOI
  41. 2018, Embryotoxic cytokines-Potential roles in embryo loss and fetal programming, J Reprod Immunol, 125, 80, 10.1016/j.jri.2017.12.003 · DOI
  42. 10.1051/medsci/20031967725 · DOI · Paper page
  43. 10.1073/pnas.76.3.1333 · DOI · Paper page
  44. Kutscher LM , Shaham S . Forward and reverse mutagenesis in C. elegans. WormBook. 2014:1–26. · DOI
  45. 10.1186/gb-2009-10-3-r25 · DOI · Paper page
  46. 2012, Fast gapped-read alignment with Bowtie 2, Nature Methods, 9, 357, 10.1038/nmeth.1923 · DOI · Paper page
  47. Cingolani P , Patel VM , Coon M , Nguyen T , Land SJ , Ruden DM , et al. Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift. Front Genet. 2012;3:35. · DOI · Paper page
  48. 10.4161/fly.19695 · DOI · Paper page
  49. 10.1038/nmeth.2019 · DOI · Paper page
  50. 10.1038/27579 · DOI · Paper page
  51. 10.1534/genetics.115.179382 · DOI · Paper page
  52. 10.1534/genetics.114.169730 · DOI · Paper page
  53. 10.1371/journal.ppat.1009350 · DOI
  54. 10.1093/nar/29.9.e45 · DOI · Paper page
  55. 2014, Clustal omega, Curr Protoc Bioinformatics, 48, 13
  56. 10.1093/sysbio/syq010 · DOI · Paper page
  57. 10.1093/molbev/msx149 · DOI · Paper page
  58. Tanguy M , Veron L , Stempor P , Ahringer J , Sarkies P , Miska EA . An Alternative STAT Signaling Pathway Acts in Viral Immunity in Caenorhabditis elegans. mBio. 2017;8(5). · DOI
  59. Steinbaugh MJ , Narasimhan SD , Robida-Stubbs S , Moronetti Mazzeo LE , Dreyfuss JM , Hourihan JM , et al. Lipid-mediated regulation of SKN-1/Nrf in response to germ cell absence. Elife. 2015;4. · DOI · Paper page
  60. 10.1111/j.1474-9726.2009.00501.x · DOI · Paper page
  61. 10.1371/journal.ppat.1000982 · DOI · Paper page
  62. 10.1371/journal.pgen.1002733 · doi:10.1371/journal.pgen.1002733
  63. 10.1371/journal.pgen.0020183 · DOI · Paper page
  64. 10.1101/gr.153296.112 · DOI
  65. 10.1186/s12864-017-3689-3 · DOI
  66. 10.1101/gad.283317.116 · DOI · Paper page
  67. 10.1098/rsif.2009.0364 · doi:10.1098/rsif.2009.0364
  68. 10.1186/gb-2007-8-9-r194 · DOI · Paper page
  69. 10.1038/nature01789 · DOI · Paper page
  70. 10.1371/journal.pone.0019055 · DOI · Paper page
  71. Jiang W , Wei Y , Long Y , Owen A , Wang B , Wu X , et al. A genetic program mediates cold-warming response and promotes stress-induced phenoptosis in C. elegans. Elife. 2018;7. · DOI
  72. 10.1016/j.cub.2018.01.029 · DOI
  73. 10.1073/pnas.0404073101 · DOI · Paper page
  74. 10.1371/journal.ppat.1002074 · DOI · Paper page
  75. 10.1371/journal.pone.0024619 · DOI
  76. 10.1371/journal.pgen.1000503 · DOI
  77. 10.7554/eLife.00994 · DOI · Paper page
  78. 10.1371/journal.pbio.1000586 · DOI · Paper page
  79. 2014, Santeuil and Le Blanc viruses primarily infect intestinal cells in Caenorhabditis nematodes, Virology, 448, 255, 10.1016/j.virol.2013.09.024 · DOI
  80. Rivera DE , Lazetic V , Troemel ER , Luallen RJ . RNA Fluorescence in situ Hybridization (FISH) to Visualize Microbial Colonization and Infection in Caenorhabditis elegans Intestines. J Vis Exp. 2022(185). · DOI
  81. 10.1371/journal.ppat.1004583 · DOI

Metadata

Authors
Lažetić, V., Blanchard, M. J., Bui, T., & Troemel, E. R.
Affiliations
University of California San Diego (US)
Corresponding author
Troemel, Emily R.
Venue
PLoS Pathogens
Publisher
openRxiv
Published
2023-01-18
Volume
19
Issue
7
Pages
e1011120-e1011120
ISSN
1553-7366 (ISSN-L)
OpenAlex
W4384664978
Cited by
35
References
1
Citations by year
2026: 10 · 2025: 11 · 2024: 10 · 2023: 4
FWCI
3.82
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Science Foundation (2301657)
  • American Heart Association (S10 OD026929, 19POST34460023)
  • National Institutes of Health (1s10od026929-01, AG052622)
  • University of California, San Diego (#S10 OD026929)
  • National Institute on Aging (AG052622, R56AG052622, R01AG052622)
  • National Institute of General Medical Sciences (R01GM114139, GM114139)
  • National Institute of Allergy and Infectious Diseases (AI176639, R01AI176639)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Invertebrate Immune Response Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
Orsay virus, microsporidia, intestinal epithelium, transcriptional regulation, Caenorhabditis elegans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.